FLOT2 and nasopharyngeal carcinoma: Zhao et al. [37] recently suggested that in nasopharyngeal carcinoma, Flot2 is an indispensable member for transforming growth factor-β (TGF-β) family signaling, which epithelial cells receive from their micro-environment to drive EMT during cancer progression [38–40].